Astigmatism – Market Outlook, Epidemiology, Competitive Landscape, and Market Forecast Report – 2023 To 2033


 

Astigmatism, a prevalent refractive error, is characterized by alterations in the refraction of light in different eye meridians. This condition results in the failure of parallel rays of light passing through the cornea to converge on the retina at a single focal point. Astigmatism can manifest as either regular or irregular. Typical symptoms include asthenopia, discomfort, blurred and defective vision, elongation of objects, and difficulties with accommodation. Signs of astigmatism include partial lid closure, head tilt, vertically oval or tilted optic disc, and varying power in different meridians. The underlying causes of astigmatism can be attributed to corneal, lenticular, or retinal factors. Regular astigmatism can further be classified into "with the rule" astigmatism, "against the rule" astigmatism, oblique astigmatism, and bi-oblique astigmatism. The principles of Sturm's conoid elucidate the optics of regular astigmatism. In regular astigmatism cases, parallel light rays converge into two focal lines rather than focusing on a singular point. The arrangement of rays refracted through the toric surface is known as Sturm's conoid, and the distance between these lines is referred to as the focal interval of Sturm. Infants and neonates tend to exhibit higher degrees of astigmatism. Approximately 40 percent of newborns have around 1 diopter of astigmatism at birth, which typically diminishes to adult levels by one year due to normal eye maturation and globe remodeling. Treatment for regular astigmatism typically involves prescribing spectacles with cylindrical lenses that are determined after accurate refraction. Another option for correcting astigmatism is using rigid contact lenses, which can correct up to 2-3 diopters of astigmatism. Toric contact lenses are recommended for astigmatism exceeding this range. The prognosis for individuals with astigmatism is generally favorable if treated promptly, as there are several options for correction. Failure to treat astigmatism, particularly during childhood, can permanently reduce visual acuity and the development of amblyopia. It is important to note that astigmatism may change over time, necessitating new glasses and contact lenses. Refractive correction often successfully eliminates or reduces astigmatism in most cases. Individuals with keratoconus risk experiencing a decline in visual acuity due to high astigmatism, underscoring the need for timely and regular screenings.

  • The prevalence of astigmatism in the general population varied from 7.6% to 61.7%, with higher rates in older individuals (≥70 years).
  • The prevalence of with-the-rule astigmatism was higher in the younger population (≤40 years), while rates of against-the-rule and oblique astigmatism increased with age.

Thelansis’s “Astigmatism Market Outlook, Epidemiology, Competitive Landscape, and Market Forecast Report – 2023 To 2033" covers disease overview, epidemiology, drug utilization, prescription share analysis, competitive landscape, clinical practice, regulatory landscape, patient share, market uptake, market forecast, and key market insights under the potential Astigmatism treatment modalities options for eight major markets (USA, Germany, France, Italy, Spain, UK, Japan, and China).

KOLs insights of Astigmatism across 8 MM market from the centre of Excellence/ Public/ Private hospitals participated in the study. Insights around current treatment landscape, epidemiology, clinical characteristics, future treatment paradigm, and Unmet needs.

Astigmatism Market Forecast Patient Based Forecast Model (MS. Excel Based Automated Dashboard), which Data Inputs with sourcing, Market Event, and Product Event, Country specific Forecast Model, Market uptake and patient share uptake, Attribute Analysis, Analog Analysis, Disease burden, and pricing scenario, Summary, and Insights.

Thelansis Competitive Intelligence (CI) practice has been established based on a deep understanding of the pharma/biotech business environment to provide an optimized support system to all levels of the decision-making process. It enables business leaders in forward-thinking and proactive decision-making. Thelansis supports scientific and commercial teams in seamless CI support by creating an AI/ ML-based technology-driven platform that manages the data flow from primary and secondary sources.

Read more: Astigmatism – Market Outlook, Epidemiology, Competitive Landscape, and Market Forecast Report – 2023 To 2033

Comments

Post a Comment

Popular posts from this blog

Acne Vulgaris – Market Outlook, Epidemiology, Competitive Landscape, and Market Forecast Report – 2022 To 2032

Image
  Acne vulgaris, a prevalent pilosebaceous unit inflammatory skin disorder, follows a persistent course. Typically presenting as papules, pustules, or nodules, it primarily occurs on the face but can also impact the upper arms, trunk, and back. The development of acne results from the sebaceous glands' heightened sensitivity to normal androgen levels, aggravated by Cutibacterium acnes (formerly known as Propionibacterium acnes), a bacterial species that triggers inflammation. The pathogenesis of acne vulgaris involves a complex interplay of factors such as the activation of sebaceous glands by androgens, imbalances in the pilosebaceous follicle microbiome, and cellular immune responses. Genetic predisposition and dietary influences also contribute to the condition's onset and progression. The initial stage is the micro-comedo, a small plug primarily composed of corneocytes in the lower follicular infundibulum. Microcomedones evolve into various acne lesions, including closed co...
Read more

Herpes Simplex Virus (HSV) – Market Outlook, Epidemiology, Competitive Landscape, and Market Forecast Report – 2023 To 2033

Image
 Herpes simplex virus (HSV) causes an infection that affects the external genitalia, anal region, mucosal surfaces, and skin in other body parts. Herpes simplex virus is a ubiquitous, host-adapted pathogen that causes various disease states. There are two types of HSV with two distinct DNA viruses, type 1 (HSV-1) and type 2 (HSV-2). Both the types are closely related but differ epidemiologically. HSV-1 is traditionally associated with orofacial disease by affecting the mouth and lips with fever blisters and cold sores, whereas HSV-2 is associated traditionally with genital disease infecting genitals and rectum area with sores and is classified as STD (sexually transmitted disease). As HSV-1 is associated with genital infections more often than HSV-2, lesion location is not necessarily of viral type. HSV can spread through direct contact. Almost 80% of Herpes simplex infections are asymptomatic, while symptomatic infections can be characterized by significant morbidity and recurrenc...
Read more

HR+/HER2- Breast Cancer – Market Outlook, Epidemiology, Competitive Landscape, and Market Forecast Report – 2023 To 2033

Image
Thelansis’s “HR+/HER2- Breast Cancer Market Outlook, Epidemiology, Competitive Landscape, and Market Forecast Report – 2023 To 2033" covers disease overview, epidemiology, drug utilization, prescription share analysis, competitive landscape, clinical practice, regulatory landscape, patient share, market uptake, market forecast, and key market insights under the potential HR+/HER2- Breast Cancer treatment modalities options for eight major markets (USA, Germany, France, Italy, Spain, UK, Japan, and China). KOLs insights of HR+/HER2- Breast Cancer across 8 MM market from the centre of Excellence/ Public/ Private hospitals participated in the study. Insights around current treatment landscape, epidemiology, clinical characteristics, future treatment paradigm, and Unmet needs. HR+/HER2- Breast Cancer Market Forecast Patient Based Forecast Model (MS. Excel Based Automated Dashboard), which Data Inputs with sourcing, Market Event, and Product Event, Country specific Forecast Model,...
Read more